UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000003481
Receipt number R000004214
Scientific Title Study on Factors Osteoporosis Quality-of-life in Japanese Subjects
Date of disclosure of the study information 2010/04/13
Last modified on 2018/08/22 19:12:39

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Study on Factors Osteoporosis Quality-of-life in Japanese Subjects

Acronym

Study on Factors Osteoporosis Quality-of-life in Japanese Subjects

Scientific Title

Study on Factors Osteoporosis Quality-of-life in Japanese Subjects

Scientific Title:Acronym

Study on Factors Osteoporosis Quality-of-life in Japanese Subjects

Region

Japan


Condition

Condition

Osteoporpsis

Classification by specialty

Medicine in general Clinical immunology Obstetrics and Gynecology
Orthopedics

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

This is an observationall study and patient questionnaire to investigate quality of life (QOL) and pain management in Japanese osteoporosis patients who have started osteoporosis treatment (bisphosphonate).

Basic objectives2

Others

Basic objectives -Others

This is an observationall study and patient questionnaire to investigate quality of life (QOL) and pain management in Japanese osteoporosis patients who have started osteoporosis treatment (bisphosphonate).

Trial characteristics_1

Confirmatory

Trial characteristics_2

Pragmatic

Developmental phase

Not applicable


Assessment

Primary outcomes

QOL,compliance

Key secondary outcomes

Pain, BMD


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

55 years-old <=

Age-upper limit


Not applicable

Gender

Female

Key inclusion criteria

As follows:
1) Japanese women of 55years old or older
2) Patients diagnosed as osteoporosis
3) Patients who have initiated osteoporosis treatment (bisphosphonate) in the past 30days
4) Patients who can fill out the patientquestionnaire adequately after granting informed consent

Key exclusion criteria

1) Women under 55 years old of age
2) Patients who have ever experienced any bisphosphonate treatment within the last 6 months from the date of initiating bisphosphonate
3) Patients already participating in other osteoporosis related clinical trials for the purpose of regulatory approval at the time of enrollment

Target sample size

6000


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Toshitaka Nakamura

Organization

UNIVERSITY OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH, JAPAN

Division name

Orthopedic surgery, professor

Zip code


Address

1-1, Iseigaoka, Yahata-nishi-ku, Kitakyushu, Fukuoka, 807-8555, Japan

TEL

093-603-1611

Email

k-ishii@apoplus.co.jp


Public contact

Name of contact person

1st name
Middle name
Last name kiyomi ishii

Organization

APO PLUS STATION Co.,LTD

Division name

Clinical Study Dept.CRO Business Div

Zip code


Address

2-14-1,Nihonbashi,Chuo-ku,Tokyo 103-0027 Japan

TEL

03-6386-8800

Homepage URL


Email

k-ishii@apoplus.co.jp


Sponsor or person

Institute

Japan Association of Health Service

Institute

Department

Personal name



Funding Source

Organization

Japan Association of Health Service

Organization

Division

Category of Funding Organization

Non profit foundation

Nationality of Funding Organization

Japan


Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2010 Year 04 Month 13 Day


Related information

URL releasing protocol


Publication of results

Partially published


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2009 Year 09 Month 17 Day

Date of IRB


Anticipated trial start date

2009 Year 10 Month 01 Day

Last follow-up date

2013 Year 05 Month 01 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded

2013 Year 09 Month 01 Day


Other

Other related information

The study is a prospective multi-center observational study using medical record review and patient questionnaires to review QOL and pain management in Japanese osteoporosis patients receiving once-weekly bisphosphonate treatment.
Osteoporosis patients already receiving once-weekly bisphosphonate treatment will be enrolled in the one year period from November 1, 2009 to October 31, 2009 with a two-year observational period from date of enrollment in order to review pain and QOL issues.


Management information

Registered date

2010 Year 04 Month 13 Day

Last modified on

2018 Year 08 Month 22 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000004214


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name